First Capital Advisors Group’s Idexx Laboratories IDXX Stock Holding History

First Capital Advisors Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$14.6K	Buy	+29	New	+$13.9K	0.01%	475
2018 Q2	–	Sell	-190	Closed	-$36K	–	439
2018 Q1	$36K	Buy	+190	New	+$35.1K	0.02%	319

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

First Capital Advisors Group's IDXX Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in Idexx Laboratories (IDXX) in Q2 2023: 29 shares worth $14.6K. The stake represents 0.01% of the portfolio and ranks #475 among its holdings. This is a return to the name: First Capital Advisors Group previously reported a position in IDXX as recently as Q1 2018.

First Capital Advisors Group first reported a position in IDXX in Q1 2018 and has held it in 2 quarters since. The position peaked at $36K in Q1 2018. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

First Capital Advisors Group held 29 shares of Idexx Laboratories worth $14.6K as of Q2 2023.
Idexx Laboratories was a new First Capital Advisors Group position in Q2 2023.
Idexx Laboratories made up 0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #475 holding.
First Capital Advisors Group first reported a position in Idexx Laboratories in Q1 2018 and has held it in 2 quarters since.
First Capital Advisors Group's Idexx Laboratories position peaked at $36K in Q1 2018.
1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.